»
Antikörper
»
anti-B-Cell CLL-lymphoma 10 BCL10
B-Cell CLL/lymphoma 10 (BCL10) Antikörper
| Antigen |
|
| Synonyme |
CLAP, mE10, CIPER, c-E10, CARMEN, ME10, cE10, BCL-10, C81403, AI132454, BCL10, MGC108338 |
| Klonalität |
Monoklonal (Carmen-1) |
|
Wirt
|
|
|
Reaktivität
|
|
|
Applikation
|
|
| Produktnummer |
ABIN187542 |
| Menge |
0.1 mg |
| Preis |
510,00 € Zzgl. Versandkosten €20,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Versandbereit innerhalb von 7 bis 10 Werktagen |
|
Weitere Bezeichnung
|
Bcl-10
|
|
Immunogen
|
Recombinant human Bcl10.
|
|
Isotyp
|
IgM (Passende Sekundärantikörper)
|
|
Klon
|
Carmen-1
|
|
Spezifität
|
Recognizes human and mouse Bcl10. Species Reactivity: Human and mouse, others not tested.
|
|
Applikationshinweise
|
Western blotting The optimal dilution for a specific application should be determined by the researcher. Method: Cell extracts from HEK 293T cells (5x103) transfected with mouse and human Bcl-10-expression plasmid were resolved by SDS-PAGE under reducing conditions, transferred to nitrocellulose and incubated with Carmen-1 at 1 µg/ml. Proteins were visualized using a peroxidase-conjugated antibody to rat IgM and a chemiluminescence detection system.
|
|
Buffer
|
100 µl of purified antibody in PBS containing 0.02% sodium azide. Concentration is 1 mg/ml.
|
|
Lagerung
|
Store at 2 - 8 °C only.
|
|
Forschungsgebiet
|
Krebs
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
Alternativen zu Antigen "B-Cell CLL/lymphoma 10 (BCL10)", Typ "Antikörper" finden
|
Wirte
|
Kaninchen (28), Maus (21), Ratte (1)
|
|
Reaktivitäten
|
Human (49), Maus (9), Ratte (Rattus) (7)
|
|
Applikationen
|
Western Blot (WB) (38), Immunhistochemie (Paraffinschnitte) (IHC (p)) (21), Immunhistochemie (Gefrierschnitte) (IHC (fro)) (7), Immunpräzipitation (IP) (6), Enzyme Immunoassay (EIA) (5), Durchflusszytometrie (FACS) (5), Immunfluoreszenz (IF) (5), Immunhistochemie (IHC) (5), ELISA (3), Immunzytochemie (ICC) (1)
|
|
Konjugate
|
RPE (1)
|
|
Epitope
|
C-Term (2), N-Term (1), pSer138 (1)
|
Alternativen 
